| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | +130.2% |
| R&D Expense | $7.7M | +23.2% |
| SG&A Expense | $12.4M | +35.7% |
| Operating Income | -$18.2M | -23.6% |
| Pre-tax Income | -$17.9M | -25.6% |
| Net Income | -$17.9M | -25.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $239K | +143.9% |
| Current Assets | $5.7M | -43.9% |
| Total Assets | $10.0M | -31.0% |
| Current Liabilities | $1.4M | -54.1% |
| Total Liabilities | $1.4M | -54.1% |
| Stockholders' Equity | $8.6M | -25.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.0M | -29.0% |
| Investing Cash Flow | -$22K | +66.4% |
| Financing Cash Flow | $11.2M | +11.7% |